menu search

DXCM / EVP Managing Director Steven Pacelli Sells 412 Shares of DexCom Inc

EVP Managing Director Steven Pacelli Sells 412 Shares of DexCom Inc
On July 24, 2023, Steven Pacelli, the Executive Vice President and Managing Director of DexCom Inc ( DXCM , Financial), sold 412 shares of the company. This move is part of a broader trend of insider selling at DexCom Inc over the past year. Read More
Posted: Jul 25 2023, 12:01
Author Name: GuruFocus
Views: 091961

DXCM News  

2 Growth Stocks That Could Help Set You Up for Life

By The Motley Fool
November 2, 2023

2 Growth Stocks That Could Help Set You Up for Life

Healthcare and e-commerce are two massive, lucrative industries that aren't slowing down. DexCom is riding on a wave of profits and cash from its late more_horizontal

3 Reasons Growth Investors Will Love DexCom (DXCM)

By Zacks Investment Research
October 31, 2023

3 Reasons Growth Investors Will Love DexCom (DXCM)

DexCom (DXCM) is well positioned to outperform the market, as it exhibits above-average growth in financials. more_horizontal

What Makes DexCom (DXCM) a New Buy Stock

By Zacks Investment Research
October 31, 2023

What Makes DexCom (DXCM) a New Buy Stock

DexCom (DXCM) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy). more_horizontal

Dexcom stock climbs as worries surrounding weight-loss drugs fades

By CNBC Television
October 27, 2023

Dexcom stock climbs as worries surrounding weight-loss drugs fades

CNBC's Angelica Peebles joins 'Closing Bell Overtime' to take a closer look at stock movers in the healthcare sector. more_horizontal

Dexcom Stock Soars on Earnings. Ozempic Isn't the Threat It Was Supposed to Be

By Barrons
October 27, 2023

Dexcom Stock Soars on Earnings. Ozempic Isn't the Threat It Was Supposed to Be

The maker of continuous glucose monitoring devices said there was no sign weight-loss drugs were hurting demand for its products. more_horizontal

DexCom (DXCM) Beats on Q3 Earnings, Raises Sales Outlook

By Zacks Investment Research
October 27, 2023

DexCom (DXCM) Beats on Q3 Earnings, Raises Sales Outlook

DexCom's (DXCM) third-quarter 2023 results reflect strong domestic and international revenue growth on the back of its real-time Continuous Glucose Mo more_horizontal

Dexcom, Inc. (DXCM) Q3 2023 Earnings Call Transcript

By Seeking Alpha
October 26, 2023

Dexcom, Inc. (DXCM) Q3 2023 Earnings Call Transcript

Dexcom, Inc. (NASDAQ:DXCM ) Q3 2023 Earnings Conference Call October 26, 2023 4:30 PM ET Company Participants Sean Christensen - Director, Corporate A more_horizontal

DexCom (DXCM) Reports Q3 Earnings: What Key Metrics Have to Say

By Zacks Investment Research
October 26, 2023

DexCom (DXCM) Reports Q3 Earnings: What Key Metrics Have to Say

The headline numbers for DexCom (DXCM) give insight into how the company performed in the quarter ended September 2023, but it may be worthwhile to co more_horizontal


Search within

Pages Search Results: